neural-lineage cells for neurological protocols.
Neurogenic (neural-lineage) cells are directed toward neuronal and glial phenotypes and are studied in neurodegenerative and neurodevelopmental contexts.
The therapeutic value of Neurogenic Cells lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.
Educational information. Neurogenic Cells protocols for several conditions remain investigational; outcomes vary by patient.
GMP-certified regenerative medicine in the heart of the EU — from €3,000–8,000, a fraction of US or German pricing. Personalised protocols for international patients from 50+ countries.
Free medical review